-
Attention to sex differences, relapse needed in early-stage studies of medication to treat alcohol use disorder
Early-stage studies of medications to treat high-risk alcohol use may be missing opportunities to identify potential therapeutic effects in certain... Read more -
New post-hoc analysis examined daily oral orforglipron in adults over 65 with obesity, with or without diabetes
A new analysis presented at the European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12–15 May) examined daily oral orforglipron... Read more -
Treatment-resistant depression may yield to combinations of medications already in clinical use
Many people with major depressive disorder get no relief from current treatments. Newer combinations of existing medications might help, researchers... Read more -
Nasal spray developed for prehospital emergency aid for ischemic stroke
A research team from Department of Pharmacology and Pharmacy at the LKS Faculty of Medicine, the University of Hong Kong... Read more -
RFK Jr. launches plan to curb antidepressant 'overprescription'
A new federal initiative aims to curb "overprescribing" of psychiatric medications while emphasizing holistic care.... Read more -
Higher-dose ivermectin no better than standard dose for severe scabies
For adults with severe scabies, higher-dose ivermectin plus permethrin is not superior to standard-dose ivermectin plus permethrin, according to a... Read more -
Gold-coated microneedles can detect subtleties in how liver and kidneys process drugs in real time
Scientists have taken a giant leap forward with the development of tiny microneedles designed to detect subtle but critical changes... Read more -
Technology receives FDA approval for breast cancer treatment
More than a decade ago, Yale chemist Craig Crews founded a biotechnology company in New Haven based on his pioneering... Read more -
Metformin's real power may be in the gut
For decades, physicians and scientists thought metformin, the leading type 2 diabetes medication taken by millions worldwide, mainly targets the... Read more -
FDA approves Auvelity for Alzheimer's disease-related agitation
The U.S. Food and Drug Administration has approved the expanded use of Axsome Therapeutics' Auvelity (dextromethorphan hydrobromide and bupropion hydrochloride)... Read more -
Leukemia stem cells cause treatments to fail, but findings open new avenues to overcome resistance
Scientists from the German Cancer Research Center (DKFZ) and the HI-STEM Stem Cell Institute have deciphered a key mechanism that... Read more -
Can peptide injections help people recover from injuries? Here's what you need to know
It's tough to avoid the current hype about the health benefits of injecting peptides. Although these substances—essentially, synthetic bits of... Read more -
Scientists take crucial step in developing world's first measles treatment
Scientists at La Jolla Institute for Immunology (LJI) are the first in the world to characterize human antibodies capable of... Read more -
Garlic-derived compound shows potential to improve muscle health during aging
Can a compound derived from a common kitchen ingredient help support muscle health during aging? A new study suggests it... Read more -
New research raises concerns about safety of higher-THC medicinal cannabis products in Australia
New Monash University research has found that more than half of all adverse events reported to Australia's medicines regulator involving... Read more
